“Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido Thiazolyl Resorcinol) in Melasma”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s544. https://doi.org/10.25251/skin.10.supp.544.